Prof Pierce CHOW
Co-Director (Surgical), Comprehensive Liver Cancer Clinic
National Cancer Centre Singapore
Senior Consultant Surgeon
Hepato-pancreato-biliary and Transplant Surgery
Singapore General Hospital.
Programme Director, PhD Programme in Clinical Sciences
Duke-NUS Medical School
Professor Pierce Chow is Senior Consultant and Co-Director (Surgical) of the Comprehensive Liver Cancer Clinic at the National Cancer Centre Singapore, Senior Consultant Surgeon in Hepato-pancreato-biliary and Transplant Surgery at the Singapore General Hospital. He is concurrently Professor and Course Director at the Duke-NUS Medical School Singapore and Adjunct Faculty at the Genome Institute of Singapore. Prof Chow was the Chapter of Surgeon’s Gold Medallist at the conjoint Royal College of Surgeons of Edinburgh/M.Med (Surgery) examination in 1994 and subsequently completed a clinical fellowship in Liver Transplantation at the Queensland Liver Transplant Service. In 1995, he was recipient of the Young Surgeon’s Award of the Academy of Medicine Singapore for his research into the patho-physiology of liver blood flow and regeneration.
In addition to managing a busy HPB surgical oncology service, Prof Chow has researched extensively on hepatocellular carcinoma (HCC). He is actively involved in clinical trials on novel therapies and leads collaborative multi-disciplinary research on intra-tumoral genomic, immunomic and metabolomic heterogeneity in HCC and their applications to precision medicine. He co-founded the Asia-Pacific Hepatocellular Carcinoma Trials Group in 1997 and has been the protocol chair of 7 prospective multi-national trials including the SIRveNIB trial which closed in 2016. In 2005 he led the multi-disciplinary research that developed BrachySil® (now OncoSil®) and the subsequent first-in-man trial. In 2012 the National Medical Research Council Singapore conferred him the National Outstanding Clinician-Scientist Award for improving clinical outcomes of patients with his research on Liver Cancer. Prof Chow was awarded the NMRC Translational-Clinical Research Grant for the Flagship Program in Liver Cancer in 2016 and has commenced the multi-national PLANET study (Precision Medicine in Liver Cancer Asia-Pacific Network). In 2017, Prof Chow further received funding from NMRC Clinician Scientist Award (Senior Investigator) to further establish a genomics-immunomics-phenomics platform under the Flagship Program in Liver Cancer and BMRC for the multi-institutional PuRPOSE Program to develop a patient-specific diagnostic and predictive platform to improve treatment of liver cancer. His latest appointment sees him as the Co-Program Director of the PuRPOSE program in collaboration with Samsung Medical Center.